Actavis on Wednesday announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of Forest Labs, which is anticipated at mid-year.
Dr. Reddy's Labs has named Satish Reddy as chairman of the board. Reddy previously held the position of vice-chairman, managing director and COO. GV Prasad will continue to serve as CEO and provide leadership to the company in an executive capacity.
Following her appearance at the 2nd Annual World Congress Summit to Improve Adherence & Enhance Patient Engagement in Philadelphia, Kristi Rudkin, senior director of product development for Walgreens, spoke with DSN about the company’s efforts to boost patients’ adherence rates.